Skip to main content

Trajectory of Mobility Decline by Type of Dementia

Buy Article:

$57.00 + tax (Refund Policy)

Cognitive and physical aspects of functionality are closely related. However, whether physical decline differs by dementia type and progression rate is debatable. To address these issues, we conducted a longitudinal study of 766 older adults whose physical performance and cognitive status were assessed annually with standard assessment tools [eg, Physical Performance Test, Clinical Dementia Rate (CDR)] for 8 years. Compared with participants who remained cognitively normal, those progressing to later-stage dementia (CDR=1) declined in their mobility by a factor of 2.82 (P<0.001), followed by those who maintained a later-stage diagnosis (slope=−1.84, P<0.001), those progressing from early-stage to later-stage (CDR=0.5 to CDR=1) dementia (slope=−1.20, P<0.001), and those who progressed to early-stage dementia (slope=−0.39, P=0.038) suggesting a steeper physical decline with dementia progression, particularly in those with the fastest disease progression. Although all types of dementia experienced mobility decline, those progressing to non-Alzheimer disease (AD) dementias, especially vascular dementia declined faster than those who remained normal (slope=−2.70, P<0.001) or progressed to AD (slope=−2.18, P<0.001). These associations were better captured by the gait/balance component of physical functionality. Our findings suggest that rapidly progressing dementia patients particularly those with non-AD subtypes should be targeted for interventions to maintain or improve gait/balance and prevent functional decline and disability although AD patients may also benefit.

Keywords: Alzheimer disease; dementia with Lewy bodies; frontotemporal dementia; mobility; physical functional decline; vascular dementia

Document Type: Research Article

Affiliations: 1: Departments of Neurology, Psychiatry, and Population Health, Alzheimer’s Disease Center, Center for Cognitive Neurology, New York University School of Medicine, New York, NY 2: Charles F. and Joanne Knight Alzheimer’s Disease Research Center, Washington University, St Louis, MO

Publication date: 01 January 2016

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content